Draft:Harry Destecroix
| Submission declined on 24 September 2024 by Johannes Maximilian (talk). This submission's references do not show that the subject qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published, reliable, secondary sources that are independent of the subject (see the guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see technical help and learn about mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|  |
| Submission declined on 1 May 2024 by Clearfrienda (talk). This submission's references do not show that the subject qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published, reliable, secondary sources that are independent of the subject (see the guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see technical help and learn about mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia. This submission appears to read more like an advertisement than an entry in an encyclopedia. Encyclopedia articles need to be written from a neutral point of view, and should refer to a range of independent, reliable, published sources, not just to materials produced by the creator of the subject being discussed. This is important so that the article can meet Wikipedia's verifiability policy and the notability of the subject can be established. If you still feel that this subject is worthy of inclusion in Wikipedia, please rewrite your submission to comply with these policies. Declined by Clearfrienda 6 months ago. | |
 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
Harry Destecroix | |
|---|---|
| Born | 10 April 1987 |
| Occupation(s) | Entrepreneur, Investor, Scientist |
| Known for | Science Creates, Ziylo, SCVC |
Harry Destecroix (born 10 April 1987) is a British scientist, entrepreneur, and investor. Harry co-founded the biotech start-up Ziylo which was acquired by Novo Nordisk for up to $800 million in 2018.[1][2]. He founded Science Creates in 2017 which has established two deep tech incubators in Bristol, with a third in development[3][4], and two UKRI-funded accelerator programs for engineering biology[5][6][7]. Harry is founder and Managing Partner of SCVC, a Venture Capital firm that invests in early-stage deep tech start-ups[8][9][10][11].
Career
[edit]- 2014: Founded Ziylo during his PhD[12].
- 2015: Founded Science Creates, an organisation that supports scientific spin-outs and entrepreneurship[13][14].
- 2018: Ziylo was acquired by Novo Nordisk for up to $800 million[1][2][15][16][17].
- 2020: Founded SCVC, a Venture Capital firm investing in deep tech start-ups[8][9][10][11].
- 2023: Launched Science Creates engineering biology accelerator supported by UKRI[5].
- 2023: Advised the UK government's review of university spin-out companies [18].
- 2024: Launched Science Creates second engineering biology accelerator[6].
Public and Political Activities
[edit]Destecroix advised the UK Government's Independent Review of University Spin-out Companies in November 2023[18]. The UK Government funding agency for innovation (UKRI) has funded two Science Creates accelerator programs for engineering biology[5].
Awards
[edit]- OBN Award for Best Sector Support Organisation 2018[19].
- UKBAA Angel Investment Awards - Exit of the Year 2019[20].
- Barclays Entrepreneur Awards - National Icon of the Year 2023[21].
- Chemistry World - Entrepreneur of the Year 2023[22].
- Growth Investor Awards - Emerging VC of the Year 2023[23]
References
[edit]- ^ a b Milne, Gemma. "Bristol Diabetes Spin-Out Acquired By Novo Nordisk For $800M". Forbes. Retrieved 2024-01-30.
- ^ a b Tirumalaraju, Divya (2018-08-19). "Novo Nordisk acquires Ziylo in a deal valued up to $800m". Pharmaceutical Technology. Retrieved 2024-07-04.
- ^ Bristol, University of. "November: science-creates | News and features | University of Bristol". www.bristol.ac.uk. Retrieved 2024-01-31.
- ^ "Deal for £8.5m 'deep tech' building at University of Bristol". www.bbc.com. Retrieved 2024-01-31.
- ^ a b c "UKRI and Science Creates launch engineering biology accelerator". www.ukri.org. 2023-06-22. Retrieved 2024-01-31.
- ^ a b "Leading VC partnerships to support engineering biology accelerator". www.ukri.org. 2024-02-29. Retrieved 2024-07-04.
- ^ "Accelerator for science tech start-ups opens for applications". Business Live. 2024-03-01. Retrieved 2024-07-04.
- ^ a b "Bristol entrepreneur who exited for up to $800M doubles-down on the city with deep-tech incubator and VC fund". TechCrunch. 2020-12-08. Retrieved 2024-01-31.
- ^ a b "UK deep tech gets another boost with new $100M SCVC fund out of Bristol". TechCrunch. 2023-09-14. Retrieved 2024-07-04.
- ^ a b "UK's most successful deeptech founders unite for the first time". Startups Magazine. Retrieved 2024-07-04.
- ^ a b "SCVC's new fund to propel Pre-Seed and Seed stage tech innovation". Tech.eu. 2023-09-14. Retrieved 2024-07-04.
- ^ Bristol, University of. "July: Ziylo | News and features | University of Bristol". bristol.ac.uk. Retrieved 2024-07-04.
- ^ Extance2016-11-22T14:32:00+00:00, Andy. "Chemist's struggles spawn Bristol lab incubator". Chemistry World. Retrieved 2024-01-31.
{{cite web}}: CS1 maint: numeric names: authors list (link) - ^ Clensy, David (2017-05-30). "Science begins to happen at extraordinary new incubation centre Unit DX". Bristol Live. Retrieved 2024-07-04.
- ^ Novo Nordisk (17 August 2018). "Novo Nordisk acquires Ziylo Ltd to accelerate its development of glucose responsive insulins" (PDF).
- ^ Bristol, University of. "August: University spin-out Ziylo acquired by global healthcare company | News and features | University of Bristol". www.bristol.ac.uk. Retrieved 2024-01-31.
- ^ Bristol, University of. "May: Ziylo award | News and features | University of Bristol". www.bristol.ac.uk. Retrieved 2024-07-04.
- ^ a b "Independent review of university spin-out companies". GOV.UK. 2023-11-22. Retrieved 2024-01-31.
- ^ "UnitDx win 2018 OBN Award for Best Sector Support Organisation | UKSPA". Retrieved 2024-01-31.
- ^ UKBAA (2021-03-19). "Harry Destecroix, winner of Exit of the Year at the 2019 UKBAA Angel Investment Awards, discusses the importance of being recognised by the awards". UK Business Angels Association. Retrieved 2024-01-31.
- ^ "Entrepreneur Awards Hall of Fame | Barclays". www.barclays.co.uk. Retrieved 2024-01-31.
- ^ "Dr Harry Destecroix - 2023 Chemistry World Entrepreneur of the Year winner". Royal Society of Chemistry. Retrieved 2024-01-31.
- ^ "Winners 2022 | Growth Investor Awards". growthinvestorawards.com. Retrieved 2024-01-31.